Evelo Biosciences Target of Unusually High Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading activity on Wednesday. Stock traders purchased 1,885 put options on the company. This is an increase of approximately 1,101% compared to the average daily volume of 157 put options.

Evelo Biosciences Stock Performance

The stock has a market capitalization of $2,000.00, a P/E ratio of 0.00 and a beta of 1.58. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $7.32. The stock has a fifty day simple moving average of $0.03 and a 200-day simple moving average of $0.04.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.